Advanced Ovarian Carcinoma

22 clinical trials · Condition

Record	Firm	Date
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)	M.D. Anderson Cancer Center	2022-04-29
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)	National Cancer Institute (NCI)	2021-11-22
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients (NCT05047926)	Mayo Clinic	2021-10-05
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)	National Cancer Institute (NCI)	2021-08-25
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors (NCT04616534)	National Cancer Institute (NCI)	2021-06-01
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial (NCT04575935)	M.D. Anderson Cancer Center	2020-08-05
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 (NCT02650986)	Roswell Park Cancer Institute	2017-07-14
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer (NCT00511992)	University of Oklahoma	2007-07-01

Track Advanced Ovarian Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.